22 Investigates: Potential dangers of GLP-1 medications SOUTH BEND, IN (WSBT) Weight-loss drugs have made headlines with famous names, like tennis superstar Serena Williams, admitting to taking them and having success
Nat Commun 15:4548 Wharton S, Calanna S, Davies M et al (2022) Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between Gastrointestinal adverse events and weight loss
Deshalb verlangen Forschende nach hochwertigen Verbindungen mit strengen Laborstandards und analytischer Transparenz
However, due to the limited number of participants, plausible explanations for this observation remain unclear
Kirby DM, Thorburn DR, Turnbull DM, Taylor RW